Newsroom
Sorted by: Latest
-
Factory Announces Madison Faulkner as Head of Strategy and Welcomes AI Veteran and NEA Partner, Lila Tretikov to Board
SAN FRANCISCO--(BUSINESS WIRE)--Factory, the creators of enterprise-ready AI coding agents, today announced that Madison Faulkner has joined the company as Head of Strategy. Faulkner, a Partner at New Enterprise Associates (NEA), has worked closely with Factory since joining the Company’s board in conjunction with NEA leading its $50 million Series B. Her move from investor to operator reflects the depth of conviction she developed working alongside the Factory team – and the opportunity she se...
-
FreedomPay and Ordr Partner to Power the Only Unified Payments Intelligence Platform in Sports and Live Entertainment
SALT LAKE CITY--(BUSINESS WIRE)--Ordr, the AI-powered payments intelligence platform for sports, live entertainment, and hospitality, and FreedomPay, the global leader in Next Level Commerce™ technologies, today announced a strategic technology partnership that will bring unified data matching, advanced gateway infrastructure, and omnichannel commerce to live experience operators worldwide. The partnership integrates FreedomPay’s commerce platform, trusted in hundreds of premier organizations g...
-
Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF
LOS ANGELES--(BUSINESS WIRE)--As Uganda and the Democratic Republic of the Congo (DRC) confront a rapidly evolving Ebola outbreak, AIDS Healthcare Foundation (AHF) warns that the crisis highlights persistent weaknesses in the world’s ability to respond quickly and equitably to emerging infectious disease threats. The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials a...
-
KBRA Assigns Preliminary Ratings to GS Mortgage-Backed Securities Trust 2026-CES3 (GSMBS 2026-CES3)
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 7 classes of mortgage-backed notes from GS Mortgage-Backed Securities Trust 2026-CES3 (GSMBS 2026-CES3), a $354.2 million RMBS transaction sponsored by Goldman Sachs Mortgage Company, entirely of closed-end second lien mortgages (CES; 100.0%). The underlying pool is seasoned approximately 6 months and comprises 3,803 loans, with AmeriSave Mortgage Corporation (41.0%) as the largest contributing originator. The collateral is characte...
-
Die Technische Universität Posen in Polen stellt den IQM-Quantencomputer vor, um Forschung und Lehre voranzutreiben
POSEN, Polen--(BUSINESS WIRE)--Die Technische Universität Posen (PUT) hat ihren ersten lokal installierten Quantencomputer in Betrieb genommen, der von IQM Quantum Computers bereitgestellt wurde, um die Ausbildung und wissenschaftliche Forschung im Bereich der Quantentechnologien voranzutreiben. Die Installation des IQM Radiance R1-Systems an der Universität steht im Einklang mit den strategischen Zielen, die in Polens Roadmap zur Entwicklung der Quantentechnologie sowie in umfassenderen europä...
-
Metro Development Group Drives More Than 2,000 Annual Home Sales in Tampa Bay with Realtor-First Strategy, High-Impact Incentives, and Exclusive Experiences
TAMPA, Fla.--(BUSINESS WIRE)--Metro Development Group is doubling down on its Realtor-first strategy, recognizing the professionals behind more than 2,000 home sales annually through high-value incentives, exclusive experiences and a year-long program designed to reward performance and deepen engagement. At the core of the strategy is the Metro MVP Realtor Program, a year-long initiative rewarding performance and strengthening Realtor relationships across Angeline (Pasco County), Sandal Key (He...
-
Samenvatting: Poznan University of Technology van Polen onthult kwantumcomputer van IQM om onderzoek en opleiding te bevorderen
POZNAN, Polen--(BUSINESS WIRE)--PUT (Poznan University of Technology) lanceerde haar eerste lokaal geïnstalleerde kwantumcomputer, geïmplementeerd door IQM Quantum Computers, om opleiding en wetenschappelijk onderzoek op gebied van kwantumtechnologieën te bevorderen. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is....
-
Samenvatting: Merz Therapeutics en Kvvit sluiten een exclusief akkoord voor INBRIJA® (levodopa inhalatiepoeder) in het vasteland van China, Hongkong en Macao
FRANKFURT, Duitsland & GANZHOU, China--(BUSINESS WIRE)--Merz Therapeutics GmbH en Jiangxi Kvvit Pharmaceutical Co. Ltd. maakten vandaag bekend dat de bedrijven een exclusief licentie- en samenwerkingsakkoord hebben gesloten met betrekking tot INBRIJA® (levodopa inhalatiepoeder) en het eigen inhalatieapparaat voor de intermitterende behandeling van episodische motorische fluctuaties (OFF-episodes) bij volwassen patiënten met de ziekte van Parkinson behandeld met een levodopa/dopa-decarboxylasere...
-
Riassunto: Merz Therapeutics e Kvvit stipulano un accordo esclusivo per INBRIJA® (levodopa polvere per inalazione) nella Cina continentale, a Hong Kong e Macao
FRANCOFORTE, Germania e GANZHOU, Cina--(BUSINESS WIRE)--Merz Therapeutics GmbH e Jiangxi Kvvit Pharmaceutical Co. Ltd. oggi hanno annunciato di aver stipulato un accordo esclusivo di licenza e collaborazione relativo a INBRIJA® (levodopa polvere per inalazione) e al suo dispositivo per inalazione proprietario per il trattamento delle fluttuazioni motorie episodiche (episodi OFF) in pazienti adulti affetti da Malattia di Parkinson (PD) trattati con levodopa in associazione a un inibitore della d...
-
Resumen: Merz Therapeutics y Kvvit firman un acuerdo exclusivo para INBRIJA® (levodopa en polvo para inhalación) en China continental, Hong Kong y Macao
FRÁNCFORT, Alemania, y GANZHOU, China--(BUSINESS WIRE)--Merz Therapeutics GmbH y Jiangxi Kvvit Pharmaceutical Co. Ltd. han anunciado hoy que ambas empresas han firmado un acuerdo exclusivo de licencia y colaboración relativo a INBRIJA® (levodopa en polvo para inhalación) y su dispositivo de inhalación patentado para el tratamiento intermitente de las fluctuaciones motoras episódicas (episodios «OFF») en pacientes adultos con enfermedad de Parkinson (EP) tratados con levodopa y un inhibidor de l...